Nonclinical Requirements for Biologics Explained: Ultimate Guide to Preclinical Testing and Regulatory Compliance Mastering Nonclinical Requirements for Biologics: Compliance-Ready Guide for Regulatory Success Introduction to Nonclinical Requirements and Their Importance Nonclinical requirements for biologics encompass pharmacology, toxicology, and safety testing conducted before clinical trials in humans. These studies are essential to evaluate the potential risks of biologics, including monoclonal antibodies, vaccines, and advanced therapies such as gene and cell therapies. Regulatory agencies like the FDA, EMA, and CDSCO mandate nonclinical data as part of Investigational New Drug (IND) or Marketing Authorization Application (MAA) submissions. By 2025, nonclinical studies are seen…